Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

15 trials with published results (10%)

Research Maturity

71 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.4%

8 terminated out of 148 trials

Success Rate

89.9%

+3.4% vs benchmark

Late-Stage Pipeline

26%

39 trials in Phase 3/4

Results Transparency

21%

15 of 71 completed with results

Key Signals

15 with results90% success

Data Visualizations

Phase Distribution

107Total
Not Applicable (41)
P 1 (7)
P 2 (20)
P 3 (16)
P 4 (23)

Trial Status

Completed71
Unknown35
Recruiting15
Not Yet Recruiting9
Terminated8
Active Not Recruiting4

Trial Success Rate

89.9%

Benchmark: 86.5%

Based on 71 completed trials

Clinical Trials (148)

Showing 20 of 20 trials
NCT04238260Not ApplicableCompleted

Enhancing Physical Therapy Best Practice for Improving Walking After Stroke

NCT04938479CompletedPrimary

D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure

NCT06486792Phase 4Recruiting

Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

NCT07563673Phase 4Not Yet RecruitingPrimary

Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)

NCT07495722Phase 1Not Yet Recruiting

Safely Quenching Complement in Stroke Survivors

NCT05871502Not ApplicableActive Not RecruitingPrimary

Glycemia and Ischemia Reperfusion Brain Injury in Patients With Acute Cerebral Infarction Treated With Mechanical Thrombectomy

NCT03176498Phase 1SuspendedPrimary

Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.

NCT03186456Phase 1SuspendedPrimary

The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction

NCT06757764Phase 4RecruitingPrimary

The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis

NCT06935279Completed

Bacteria in Atherosclerotic Plaques and Adverse Events

NCT07379190Phase 3Not Yet Recruiting

HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

NCT00200356Phase 4CompletedPrimary

Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke

NCT00147316Phase 3CompletedPrimary

Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

NCT06548971Phase 3Recruiting

Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)

NCT06018545Completed

AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation

NCT07081568Not ApplicableRecruitingPrimary

Research on Binaural Synchronous Vagus Nerve Regulation of Sensorimotor Disorders After Cerebral Infarction

NCT03318432Recruiting

Stroke Recovery Initiative - Registry for Stroke Research Studies

NCT04941482Not ApplicableCompleted

Intervention Effectiveness Towards Improving Physical and Mental Health for Post-stroke Patients.

NCT05476991Phase 3Recruiting

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

NCT07140406Not ApplicableActive Not RecruitingPrimary

Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients

Scroll to load more

Research Network

Activity Timeline